Literature DB >> 8450029

Local expression of antiinflammatory cytokines in cancer.

M Yamamura1, R L Modlin, J D Ohmen, R L Moy.   

Abstract

To characterize the nature of the local cytokine response to cancer, we chose to investigate cytokine patterns in biopsy specimens of basal cell carcinoma (BCC). We hypothesized that a distinct pattern of local cytokine production may be characteristic of BCC, a neoplasia of epidermis, in comparison to the pattern of seborrheic keratosis (SK), a benign growth of epidermis. We analyzed cytokine mRNAs in BCC versus SK by performing polymerase chain reaction on mRNA derived from biopsy specimens. The mRNAs encoding cytokines for IL-4, IL-5, IL-10, and granulocyte macrophage colony-stimulating factor were strongly expressed in BCC lesions and weakly expressed in SK lesions. Conversely, IL-2, IFN-gamma, and lymphotoxin mRNAs were strongly expressed in SK lesions and weakly expressed in BCC lesions. The response to malignancy, BCC, was typified by cytokines characteristic of murine TH2 cells. This cytokine pattern favors humoral immunity with concomitant immunosuppression of cell-mediated immune responses. In comparison, the response to the benign growth, SK, was typified by cytokines characteristic of murine TH1 cells that favor cell-mediated immune reactions. The findings of a distinct cytokine pattern in skin cancer provide a framework to develop strategies for immunologic intervention.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450029      PMCID: PMC288053          DOI: 10.1172/JCI116256

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Histologic changes in superficial basal cell epithelioma and Bowen's disease by intralesional injection of recombinant interleukin 2: recombinant interleukin 2 may induce redifferentiation of malignant tumor cells in vivo.

Authors:  M Mihara; H Nakayama; K Nakamura; T Morimura; Y Hagari; S Shimao
Journal:  Arch Dermatol       Date:  1990-08

2.  IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.

Authors:  O M Martinez; R S Gibbons; M R Garovoy; F R Aronson
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

3.  Murine interleukin-4 displays potent anti-tumor activity in vivo.

Authors:  R I Tepper; P K Pattengale; P Leder
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

4.  Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.

Authors:  P H Hart; G F Vitti; D R Burgess; G A Whitty; D S Piccoli; J A Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Cytokine regulation of antigen-driven immunoglobulin production in filarial parasite infections in humans.

Authors:  C L King; E A Ottesen; T B Nutman
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

6.  Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon.

Authors:  N Mozzanica; A Cattaneo; V Boneschi; L Brambilla; E Melotti; A F Finzi
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

7.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

Authors:  K W Moore; P Vieira; D F Fiorentino; M L Trounstine; T A Khan; T R Mosmann
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

8.  Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.

Authors:  E A Wierenga; M Snoek; C de Groot; I Chrétien; J D Bos; H M Jansen; M L Kapsenberg
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

9.  Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset.

Authors:  J C Simon; P D Cruz; P R Bergstresser; R E Tigelaar
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

10.  Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.

Authors:  B Gansbacher; K Zier; B Daniels; K Cronin; R Bannerji; E Gilboa
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Th1/Th2 balance in cancer, transplantation and pregnancy.

Authors:  M R Shurin; L Lu; P Kalinski; A M Stewart-Akers; M T Lotze
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Early effects of low dose C ion or x-ray irradiation on peripheral blood lymphocytes of patients with alimentary tract cancer.

Authors:  Yingtai Chen; Xuezhong Chen; Yumin Li; Hong Zhang; Yi Xie; Xiaowei Zhang; Huizi Ren; Yanling Wang; Shiqi Liao; Mingyan He; Jinyu Ren; Jieyu Zhang; Xiadong Zhou; Tongzhang Zheng; Briseis A Kilfoy; Yawei Zhang
Journal:  Dose Response       Date:  2010-08-02       Impact factor: 2.658

3.  The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1alpha, IL-6, GM-CSF, and KC.

Authors:  C W Smith; Z Chen; G Dong; E Loukinova; M Y Pegram; L Nicholas-Figueroa; C Van Waes
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

4.  Effect of lentiviral vector-packaged interleukin-18 gene on the malignant behavior of lung cancer.

Authors:  Xiangqi Chen; Rui Feng; Donglan Xiong; Sheng Yang; Tingyan Lin
Journal:  Exp Ther Med       Date:  2019-11-15       Impact factor: 2.447

5.  Expression of Th1- Th2- and Th17-associated cytokines in laryngeal carcinoma.

Authors:  Xiaoqun Xu; Rui Wang; Qinghong Su; Haiyan Huang; Peng Zhou; Junwen Luan; Jingsheng Liu; Junfu Wang; Xuemei Chen
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

6.  Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model.

Authors:  R C Jones; M Kelley; R K Gupta; J A Nizze; R Yee; Z Leopoldo; K Qi; S Stern; D L Morton
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

7.  Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression.

Authors:  S L Giannini; W Al-Saleh; H Piron; N Jacobs; J Doyen; J Boniver; P Delvenne
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

8.  Production of interleukin-10 by human bronchogenic carcinoma.

Authors:  D R Smith; S L Kunkel; M D Burdick; C A Wilke; M B Orringer; R I Whyte; R M Strieter
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

9.  Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma.

Authors:  W J Bateman; I Donnellan; I A Fraser; L S Wong; A G Morris
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

Review 10.  Cytokine therapeutics: lessons from interferon alpha.

Authors:  J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.